DE60203919D1 - Solvate von lercanidipin-hydrochlorid und kristalline formen von lercanidipin-hydrochlorid - Google Patents
Solvate von lercanidipin-hydrochlorid und kristalline formen von lercanidipin-hydrochloridInfo
- Publication number
- DE60203919D1 DE60203919D1 DE60203919T DE60203919T DE60203919D1 DE 60203919 D1 DE60203919 D1 DE 60203919D1 DE 60203919 T DE60203919 T DE 60203919T DE 60203919 T DE60203919 T DE 60203919T DE 60203919 D1 DE60203919 D1 DE 60203919D1
- Authority
- DE
- Germany
- Prior art keywords
- lercanidipine hydrochloride
- solvates
- crystalline forms
- lercanidipine
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI001727A ITMI20011727A1 (it) | 2001-08-06 | 2001-08-06 | Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi |
| PCT/EP2002/008700 WO2003014085A1 (en) | 2001-08-06 | 2002-08-05 | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60203919D1 true DE60203919D1 (de) | 2005-06-02 |
Family
ID=11448246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60203919T Expired - Lifetime DE60203919D1 (de) | 2001-08-06 | 2002-08-05 | Solvate von lercanidipin-hydrochlorid und kristalline formen von lercanidipin-hydrochlorid |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1423367B1 (de) |
| JP (1) | JP2005502648A (de) |
| KR (1) | KR100912664B1 (de) |
| CN (1) | CN100494175C (de) |
| AR (1) | AR037230A1 (de) |
| AT (1) | ATE294162T1 (de) |
| AU (1) | AU2002331390B2 (de) |
| BR (1) | BR0211738A (de) |
| DE (1) | DE60203919D1 (de) |
| EA (1) | EA200400279A1 (de) |
| ES (1) | ES2209684T1 (de) |
| HR (1) | HRP20040157A2 (de) |
| HU (1) | HUP0401161A3 (de) |
| IL (2) | IL153916A0 (de) |
| IT (1) | ITMI20011727A1 (de) |
| MX (1) | MXPA04001073A (de) |
| NO (1) | NO20040479L (de) |
| PE (1) | PE20030350A1 (de) |
| PL (1) | PL369449A1 (de) |
| UY (1) | UY27409A1 (de) |
| WO (1) | WO2003014085A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100651212B1 (ko) | 2004-10-27 | 2006-12-01 | 제일약품주식회사 | 무정형 레르카니디핀의 제조방법 |
| AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| US8097729B2 (en) | 2005-09-16 | 2012-01-17 | Glenmark Generics Ltd. | Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
| EP2121575A2 (de) * | 2007-03-05 | 2009-11-25 | Actavis Group PTC EHF | Lercanidipin-hydrochlorid-polymorphe und verbessertes verfahren zur herstellung von 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-amino-ethylacetoacetat |
| WO2008136394A1 (ja) * | 2007-04-27 | 2008-11-13 | Ajinomoto Co., Inc. | ラクタム化合物の製造方法及びその製造中間体 |
| EP2585051B2 (de) | 2010-06-23 | 2020-04-08 | KRKA, tovarna zdravil, d.d., Novo mesto | Pharmazeutische orale dosierformen mit lercandipin und enalapril und ihren pharmazeutisch akzeptablen salzen |
| EP2654729B1 (de) | 2010-12-24 | 2016-05-04 | KRKA, d.d., Novo mesto | Orale homogene pharmazeutische zubereitung enthaltend lercanidipine und enalapril oder ihre pharmazeutische salze zusammen mit einer organischen säure |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
| US5912351A (en) * | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
-
2001
- 2001-08-06 IT IT2001MI001727A patent/ITMI20011727A1/it unknown
-
2002
- 2002-08-02 AR ARP020102957A patent/AR037230A1/es not_active Application Discontinuation
- 2002-08-05 EP EP02767318A patent/EP1423367B1/de not_active Expired - Lifetime
- 2002-08-05 AT AT02767318T patent/ATE294162T1/de not_active IP Right Cessation
- 2002-08-05 JP JP2003519035A patent/JP2005502648A/ja active Pending
- 2002-08-05 BR BR0211738-0A patent/BR0211738A/pt not_active IP Right Cessation
- 2002-08-05 AU AU2002331390A patent/AU2002331390B2/en not_active Ceased
- 2002-08-05 ES ES02767318T patent/ES2209684T1/es active Pending
- 2002-08-05 PL PL02369449A patent/PL369449A1/xx unknown
- 2002-08-05 EA EA200400279A patent/EA200400279A1/ru unknown
- 2002-08-05 HU HU0401161A patent/HUP0401161A3/hu unknown
- 2002-08-05 MX MXPA04001073A patent/MXPA04001073A/es not_active Application Discontinuation
- 2002-08-05 WO PCT/EP2002/008700 patent/WO2003014085A1/en active IP Right Grant
- 2002-08-05 CN CNB028155114A patent/CN100494175C/zh not_active Expired - Fee Related
- 2002-08-05 KR KR1020047001791A patent/KR100912664B1/ko not_active IP Right Cessation
- 2002-08-05 DE DE60203919T patent/DE60203919D1/de not_active Expired - Lifetime
- 2002-08-05 IL IL15391602A patent/IL153916A0/xx unknown
- 2002-08-06 PE PE2002000716A patent/PE20030350A1/es not_active Application Discontinuation
- 2002-08-06 UY UY27409A patent/UY27409A1/es not_active Application Discontinuation
-
2003
- 2003-01-13 IL IL153916A patent/IL153916A/en unknown
-
2004
- 2004-02-03 NO NO20040479A patent/NO20040479L/no not_active Application Discontinuation
- 2004-02-18 HR HR20040157A patent/HRP20040157A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04001073A (es) | 2005-02-17 |
| PE20030350A1 (es) | 2003-06-06 |
| JP2005502648A (ja) | 2005-01-27 |
| WO2003014085A1 (en) | 2003-02-20 |
| IL153916A0 (en) | 2003-07-31 |
| EA200400279A1 (ru) | 2004-06-24 |
| KR100912664B1 (ko) | 2009-08-17 |
| AU2002331390B2 (en) | 2008-06-05 |
| AR037230A1 (es) | 2004-11-03 |
| NO20040479L (no) | 2004-02-03 |
| ES2209684T1 (es) | 2004-07-01 |
| ITMI20011727A1 (it) | 2003-02-06 |
| EP1423367A1 (de) | 2004-06-02 |
| HRP20040157A2 (en) | 2004-08-31 |
| UY27409A1 (es) | 2003-03-31 |
| CN1538958A (zh) | 2004-10-20 |
| CN100494175C (zh) | 2009-06-03 |
| HUP0401161A2 (hu) | 2004-09-28 |
| ITMI20011727A0 (it) | 2001-08-06 |
| BR0211738A (pt) | 2004-09-28 |
| HUP0401161A3 (en) | 2009-04-28 |
| EP1423367B1 (de) | 2005-04-27 |
| PL369449A1 (en) | 2005-04-18 |
| KR20040030932A (ko) | 2004-04-09 |
| IL153916A (en) | 2008-07-08 |
| ATE294162T1 (de) | 2005-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2017030I1 (el) | Παραγωγα πυρρολιδινης και πιπεριδινης ως ανταγωνιστες νκ1 | |
| ATE437871T1 (de) | Polymorphe formen von 1-ä4-(5-cyanoindol-3- yl)butylü-4-(2-carbamoylbenzofuran-5-yl) piperazin-hydrochlorid | |
| DK1227088T3 (da) | Krystallinsk base af citalopram og hydrochlorid- eller hydrobromidsaltet deraf | |
| IS7216A (is) | Bensamíð og heteróarýlamíð sem P2X7 viðtaka mótlyf | |
| DE60122196D1 (de) | Synergistische antioxidans-kombination von delta tocols und polyphenolen | |
| CY2008008I1 (el) | Ν-υποκατεστημενοι υδροξυπυριμιδινονο-καρβοξαμιδικοι ανσατολεις της ιντεγρασης hiv | |
| DE60227301D1 (de) | Strukturen von anschlusselementen und anzuschliessende komponente | |
| DE60217458D1 (de) | Massenspektrometer und Verfahren | |
| EP1420825A4 (de) | Immunmodulatorische verbindungen und verwendungszwecke dafür | |
| DK1202941T3 (da) | Gipssammensætninger og beslægtede fremgangsmåder | |
| DE50200786D1 (de) | Fräsmaschine und Fräsverfahren | |
| DK1411923T3 (da) | Farmaceutisk sammensætning af amlodipin og atorvastatin | |
| DE60220486D1 (de) | Zurückschaltungseinrichtung und Zurückschaltungsverfahren | |
| DE60210535D1 (de) | Vibrator und Herstellungsverfahren desselben | |
| DE60322290D1 (de) | Dielektrische Keramikzusammensetzung und Resonator | |
| ATE495169T1 (de) | Toluol-solvat von darifenacin | |
| ATE307114T1 (de) | Kristalline polymorphe formen von lercanidipin hydrochlorid und verfahren zu deren herstellung | |
| ATE294162T1 (de) | Solvate von lercanidipin-hydrochlorid und kristalline formen von lercanidipin-hydrochlorid | |
| IS6797A (is) | Ný kristal- og lausnarsambandsform ondansetrónvetnisklóríðs og aðferðir við að framleiða þau | |
| DE60106897D1 (de) | Geregelter und gedichteter schwingungsdämpfer | |
| ATE369339T1 (de) | Pseudopolymorphe formen von carvedilol | |
| DE60203475D1 (de) | Drosselklappe und Drossel | |
| NO20032091D0 (no) | Blandinger av N-(metyletylaminokarbonyl)-4-(3- metylfenylamino)-3-pyridylsulfonamid og sykliske oligosakkarider | |
| DE60238302D1 (de) | Piezoelektrischer vibrator und filter der denselben verwendet | |
| DK1440067T3 (da) | N-formyl-derivater af paroxetin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |